MedPath

Alliance for Family Integrated Care Implementation in Neonatal Intensive Care Units

Not Applicable
Recruiting
Conditions
Preterm
Interventions
Procedure: FICare
Registration Number
NCT06087666
Lead Sponsor
Instituto de Investigación Hospital Universitario La Paz
Brief Summary

International, multi-centre, pluri-cultural, stepped wedge cluster controlled trial, to demonstrate superiority of site tailored 'Family integrated care model'(FICare), that promotes the active participation of the parents as primary caregivers of their infants in neonatal intensive care units (NICU), versus standard NICU care delivery with regards to short-term health outcomes in high-risk newborns with prolonged hospital stay.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
FICare interventionFICareFICare implementation model will be demonstrated by setting 5 pilots in non-FICare-experienced NICUs from NL, TR, RO, UK, ZM (AMC, GU, CLUJ, UHS, and UNZA, partners, respectively) and 2 pilots in clinical sites who have recently implemented FICare from ES and NL (SERMAS and OLVG).
Primary Outcome Measures
NameTimeMethod
RISEinFAMILY implementation:Through study completion (average of 24 months)

Average time of kangaroo care per day

Short-term health infant's outcomesThrough study completion (average of 24 months)

proportion of high-risk infants achieving and maintaining adequate growth patterns during NICU admission.

Secondary Outcome Measures
NameTimeMethod
Feeding patterns at discharge:Through study completion (average of 24 months)

postmenstrual age (PMA) at discharge

Parental psychological healthThrough study completion (average of 24 months)

Resilience will be measured Brief Resilience Scale. Scale ranges from 0 yo 6. For items 4, 7, 9, 12, 17, 18, 19 and 21, higher scores indicate a better outcome. For items 1, 2, 3, 5, 6, 8, 10, 11, 13, 14, 15, 16m 20 and 22 a higher score indicates a worse outcome.

Proportion of infants diagnosed of (at 36 weeks PMA or discharge): bronchopulmonary dysplasia, oxygen dependency, severe retinopathy of prematurity (grade 3 or need for treatment), nosocomial infection necrotising enterocoliThrough study completion (average of 24 months)
Reported adverse event rate per 1000 patients/dayThrough study completion (average of 24 months)
Brestfeeding rates at discharge:Through study completion (average of 24 months)

Number of patients with \>50% of intake

Satisfaction and self-care of professionals measured by surveysThrough study completion (average of 24 months)

Work and wellbeing will be measured using Unwes-9 work and well-being survey (UWES).

Scale ranges from 0 to 6, a higher score indicates a better outcome

Trial Locations

Locations (2)

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Gazi University

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath